Sarcopenia and Frailty: A Common Thread Across Multiple Comorbidities

Sarcopenia and frailty share a dynamic interplay, significantly influencing the quality of life and functionality in older adults. Defined by the progressive loss of muscle mass and strength, sarcopenia often precedes and contributes to frailty—a state marked by heightened vulnerability to adverse health outcomes. Yet, sarcopenia’s progression is also exacerbated by factors associated with frailty, including inflammation, hormonal changes, and impaired nutritional status. Furthermore, the presence of additional comorbidities can amplify the impact of sarcopenia. This chapter explores the intricate relationship between these geriatric syndromes, shedding light on the bidirectional influences that intensify their effects. Importantly, potential interventions designed to mitigate these conditions are discussed. Comprehensive understanding of sarcopenia and frailty’s interconnectedness is pivotal. Such insights pave the way for interventions targeting both conditions simultaneously, aiming to enhance the quality of life and preserve functional independence during the aging process.